Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma
Abstract M2-polarized tumor-associated macrophages (TAMs) are a key factor contributing to the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). While various factors within the tumor microenvironment (TME) drive their formation, the role of PDAC-derived exosomes in this process remains unc...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07720-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850272845805912064 |
|---|---|
| author | Tianyin Ma Wing-Wa Guo Minghe Zhang Wenzhi He Cairang Dongzhi Xiangdong Gongye Peng Xia Yibo Chai Zhang Chen Yimin Zhu Chengming Qu Jie Liu Zhiyong Yang Weijie Ma Ming Tian Yufeng Yuan |
| author_facet | Tianyin Ma Wing-Wa Guo Minghe Zhang Wenzhi He Cairang Dongzhi Xiangdong Gongye Peng Xia Yibo Chai Zhang Chen Yimin Zhu Chengming Qu Jie Liu Zhiyong Yang Weijie Ma Ming Tian Yufeng Yuan |
| author_sort | Tianyin Ma |
| collection | DOAJ |
| description | Abstract M2-polarized tumor-associated macrophages (TAMs) are a key factor contributing to the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). While various factors within the tumor microenvironment (TME) drive their formation, the role of PDAC-derived exosomes in this process remains unclear. We aim to clarify the regulatory impacts of tumor-derived exosomes to TAMs. After the intratumoral injection to subcutaneous tumor of C57BL/6 mice, we demonstrated PDAC-derived exosomes exacerbate PDAC progression, accompanied with upregulated M2 phenotype of TAMs and unaffected proliferation signatures. Through intratumoral injection model and multi-Omics analyses, we identified CCT6A as a novel tumor-derived exosomal protein, bridging TAMs M2 polarization and PDAC prognosis. Co-culture with exosomes derived from CCT6Ahigh PDAC leads to greater M2 phenotype of TAMs via PI3K-AKT signaling. According to proteomics data, chemokines’ abundance reduces over tenfold once exosomal CCT6A absence, including CXCL1, CXCL3, CCL20 and CCL5, whose interaction with CCT6A in PDAC cells was confirmed by interactomics data. Moreover, we found silencing CCT6A abrogated the antagonism effects of CD47 antibody immunotherapy. Our findings implied that the subunit of the T-complex protein Ring Complex (TRiC) CCT6A serves as a matchmaker during exosome-mediated chemokines transfer from PDAC to TAMs. Silencing CCT6A effectively sensitized PDAC to CD47 antibody immunotherapy in vivo. |
| format | Article |
| id | doaj-art-e76eeebcddd04c1eaad6373ff75eb72d |
| institution | OA Journals |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-e76eeebcddd04c1eaad6373ff75eb72d2025-08-20T01:51:39ZengNature Publishing GroupCell Death and Disease2041-48892025-05-0116111410.1038/s41419-025-07720-yTumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinomaTianyin Ma0Wing-Wa Guo1Minghe Zhang2Wenzhi He3Cairang Dongzhi4Xiangdong Gongye5Peng Xia6Yibo Chai7Zhang Chen8Yimin Zhu9Chengming Qu10Jie Liu11Zhiyong Yang12Weijie Ma13Ming Tian14Yufeng Yuan15Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityDepartment of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan UniversityAbstract M2-polarized tumor-associated macrophages (TAMs) are a key factor contributing to the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). While various factors within the tumor microenvironment (TME) drive their formation, the role of PDAC-derived exosomes in this process remains unclear. We aim to clarify the regulatory impacts of tumor-derived exosomes to TAMs. After the intratumoral injection to subcutaneous tumor of C57BL/6 mice, we demonstrated PDAC-derived exosomes exacerbate PDAC progression, accompanied with upregulated M2 phenotype of TAMs and unaffected proliferation signatures. Through intratumoral injection model and multi-Omics analyses, we identified CCT6A as a novel tumor-derived exosomal protein, bridging TAMs M2 polarization and PDAC prognosis. Co-culture with exosomes derived from CCT6Ahigh PDAC leads to greater M2 phenotype of TAMs via PI3K-AKT signaling. According to proteomics data, chemokines’ abundance reduces over tenfold once exosomal CCT6A absence, including CXCL1, CXCL3, CCL20 and CCL5, whose interaction with CCT6A in PDAC cells was confirmed by interactomics data. Moreover, we found silencing CCT6A abrogated the antagonism effects of CD47 antibody immunotherapy. Our findings implied that the subunit of the T-complex protein Ring Complex (TRiC) CCT6A serves as a matchmaker during exosome-mediated chemokines transfer from PDAC to TAMs. Silencing CCT6A effectively sensitized PDAC to CD47 antibody immunotherapy in vivo.https://doi.org/10.1038/s41419-025-07720-y |
| spellingShingle | Tianyin Ma Wing-Wa Guo Minghe Zhang Wenzhi He Cairang Dongzhi Xiangdong Gongye Peng Xia Yibo Chai Zhang Chen Yimin Zhu Chengming Qu Jie Liu Zhiyong Yang Weijie Ma Ming Tian Yufeng Yuan Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma Cell Death and Disease |
| title | Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma |
| title_full | Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma |
| title_fullStr | Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma |
| title_full_unstemmed | Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma |
| title_short | Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma |
| title_sort | tumor derived exosomal cct6a serves as a matchmaker introducing chemokines to tumor associated macrophages in pancreatic ductal adenocarcinoma |
| url | https://doi.org/10.1038/s41419-025-07720-y |
| work_keys_str_mv | AT tianyinma tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT wingwaguo tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT minghezhang tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT wenzhihe tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT cairangdongzhi tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT xiangdonggongye tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT pengxia tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT yibochai tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT zhangchen tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT yiminzhu tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT chengmingqu tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT jieliu tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT zhiyongyang tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT weijiema tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT mingtian tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma AT yufengyuan tumorderivedexosomalcct6aservesasamatchmakerintroducingchemokinestotumorassociatedmacrophagesinpancreaticductaladenocarcinoma |